A New Colonialism? — Conducting Clinical Trials in India

Samiran Nundy, M. Chir, Chandra M. Gulhati | The New England Journal of Medicine | 21 April 2005

In January 2005, the government of India enacted a new rule that allows foreign pharmaceutical companies and other interested parties to conduct trials of new drugs in India at the same time that trials of the same phase are being conducted in other countries. This new rule supersedes a directive of India’s Drugs and Cosmetics Rules that required a “phase lag” between India and the rest of the world. According to the old rule, if a phase 3 study had been completed elsewhere, only a phase 2 study was permitted in India. Even under the new rule, phase 1 trials . . .

Click for details

Bookmark the permalink.

Comments are closed.